Evidence map›Paper›PMID 42488242›Full record

ArticleCureus2026

Natural Is Not Always Safe: A Case of Torsades De Pointes Induced by Berberine Supplementation.

Jeremy M Williams, Nikhita Yadlapalli, Francisco Franchi

Erratum issuedAbstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jeremy M WilliamsInternal Medicine, University of Florida (UF) Health, Jacksonville, USA.
Nikhita YadlapalliInternal Medicine, University of Florida (UF) Health, Jacksonville, USA.
Francisco FranchiCardiology, University of Florida (UF) Health, Jacksonville, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Torsades de pointes (TdP) is a life-threatening form of polymorphic ventricular tachycardia (VT) that develops in the context of QT interval prolongation. Although many prescription medications are recognized as QT-prolonging agents, the arrhythmogenic risks associated with non-FDA-approved products, such as over-the-counter (OTC) and herbal supplements, are less understood. The widespread availability of these supplements online has led to increased use as holistic alternatives to conventional pharmacologic therapy. While certain supplements may offer potential benefits for chronic diseases, most remain non-FDA-approved and lack robust randomized clinical trials to assess their safety and adverse effect profiles. Here, we present the case of a 36-year-old woman who developed a prolonged QT interval of unknown origin and subsequently suffered cardiac arrest due to TdP. It was only immediately prior to a planned invasive procedure that the patient disclosed several months of berberine use, a herbal supplement purchased online. Following discontinuation of berberine, her symptoms and EKG abnormalities resolved completely. This case underscores the unknown and potentially fatal risks associated with OTC supplements promoted as holistic alternatives to medication. Increased patient education and physician awareness regarding the prevalence and dangers of supplement use are essential for ensuring patient safety and improving outcomes.

Indexed as

berberinecardiac arrestnutrition supplementprolonged qtc intervaltorsades de pointes (tdp)

Identifiers

PMID42488242
PMCPMC13390011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.